CSA Medical Opens New Facility in Lexington, MA

-Company triples its space to advance customer training and product development-

LEXINGTON, Mass.--(BUSINESS WIRE)--CSA Medical, Inc., the leading provider of advanced spray cryotherapy technology that flash freezes and ablates unwanted tissue inside the body, today announced a corporate expansion and opening of a new 8,000+ square foot facility located at 91 Hartwell Avenue in Lexington, MA. The facility will accommodate product development and customer training to support commercialization of the company's novel truFreeze® Spray Cryotherapy system.

“We believe this additional facility and desirable location will enable us to continue to attract and retain a highly-skilled staff of engineers, clinical, regulatory and business professionals to help bring the benefits of spray cryotherapy to more patients.”

"Throughout this year, we have achieved critical milestones associated with introducing our truFreeze® technology to the market, including expanded FDA clearance. Along the way, executives from leading global medical device companies have joined the CSA Medical leadership team in the Boston area to advance the development of our technology,” said Bill Floyd, President and Chief Executive Officer. "We believe this additional facility and desirable location will enable us to continue to attract and retain a highly-skilled staff of engineers, clinical, regulatory and business professionals to help bring the benefits of spray cryotherapy to more patients.”

About CSA Medical

CSA Medical, Inc. develops and manufactures a proprietary interventional spray cryotherapy technology platform comprised of a device and specialty catheters that enable delivery of spray cryogen inside the body to flash freeze and destroy diseased tissue. The Company is the first to harness the power of low pressure, extremely cold (-196 ^o C) liquid nitrogen inside the body. To learn more, please visit www.CSAmedical.com.